BRUSSELS, July 16 (Reuters) - Nordic Capital Fund VII and Avista Capital Partners won conditional approval from the European Commission to buy the ConvaTec wound and ostomy care business of Bristol-Myers Squibb Co for $4.1 billion.
BRUSSELS, July 16 (Reuters) - Nordic Capital Fund VII and Avista Capital Partners won conditional approval from the European Commission to buy the ConvaTec wound and ostomy care business of Bristol-Myers Squibb Co for $4.1 billion.
